Raw Material Nifedipine Pharmaceutical Intermediate Nifedipine Tablet Powder Nifedipine

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: Dsung-Nifedipine
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Nifedipine
• Appearance: Yellow Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical Intermediate
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 21829-25-4
• Mf: C17h18n2o6
• MW: 346.33462
• Density: 1.271
• Melting Point: 171-175 C
• Boiling Point: 475.3 C at 760 Mmhg
• Refractive Index: 1.584
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 5 Ton/Month

Product Description

Raw Material Nifedipine Pharmaceutical Intermediate Nifedipine Tablet Powder Nifedipine

 

Product Description

Product Details

Product Name	Nifedipine
Appearance	Yellow powder
CAS No.	21829-25-4
MF	C17H18N2O6
MW	346.33462

Nifedipine, also known as 1, 4-dihydro-2, 6-dimethyl-4 -(2-nitrophenyl-3, 5-pyridine dicarboxylate), is a dihydropyridine calcium antagonist used for the prevention and treatment of angina pectoris in coronary heart disease, particularly variant angina pectoris and angina pectoris caused by coronary artery spasm. It has no adverse effect on respiratory function, so it is suitable for patients with angina pectoris suffering from respiratory obstructive diseases, and its efficacy is better than β-receptor antagonists. It is also suitable for various types of hypertension, and has a good effect on refractory and severe hypertension. Because it can reduce after-load, it also has a good effect on refractory congestive heart failure, and is suitable for long-term use.

Application & Function

1.Nifedipine can simultaneously dilate coronary arteries in the normal blood supply area and ischemic area, antagonize spontaneous or ergotrine induced coronary spasm, increase myocardial oxygen delivery in patients with coronary spasm, and relieve and prevent coronary spasm.
2.Nifedipine can inhibit myocardial contraction, decrease myocardial metabolism and reduce myocardial oxygen consumption.
3.Nifedipine can dilate peripheral resistance blood vessels, reduce peripheral resistance, reduce systolic blood pressure and diastolic blood pressure, and relieve cardiac afterload.
4.Nifedipine can delay the sinus node function and atrioventricular conduction in isolated hearts; Overall animal and human electrophysiological studies have not found that this product can delay atrioventricular conduction, prolong the recovery time of sinoatrial node and slow down the rate of sinoatrial node.

Specification